| Company Background | | | | company associated with virology Professor John |
| An overview of Sharp Corporation and the | | | | S. Oxford, University of London. |
| history of its Plasmacluster Ion technology are | | | | Though announced in the midst of the multi-year |
| instructive in understanding the extent that this | | | | bird flu pandemic scare, the world did not seem |
| company believes that its very own futuristic | | | | impressed with Sharp's claim. This, we believe, |
| state-of-the-art technology surpasses anything in | | | | was primarily due to the lack of independent |
| the air purification market. | | | | scientific peer reviews. We validated this belief by |
| | | | suggesting Sharp Plasmacluster Ion technology at |
| The company is well-known for innovative | | | | several bird flu forums and met with this precise |
| products spanning audio-visual products, home | | | | rebuttal. |
| appliances, information and communication | | | | On 19 January 2009, Sharp announced plans to |
| products, solar cells and LCDs. Its business | | | | install 10,000 Plasmacluster Ion generators at its |
| philosophy includes a dedication to "unique, | | | | offices globally to combat a pandemic of new |
| innovative technology to contribute to the culture, | | | | viruses. These ion generators produce 25,000 ions |
| benefits and welfare of people throughout the | | | | per cubic cm and catered to room sizes of 23 |
| world". | | | | square m and 50 square m. The aim is to |
| With growing global awareness about healthy | | | | deactivate harmful airborne substances in all Sharp |
| lifestyles, environmental care and energy | | | | offices, thereby ensuring the safety of |
| conservation, Sharp has declared that it will | | | | employees and to keep the company business |
| contribute to the world through an environmental | | | | running smoothly. |
| and health-conscious business as one of its visions. | | | | Rare Revelation of Marketing Strategy |
| Plasmacluster Ion technology is at the core of this | | | | On 16 January 2009, Sharp announced that sales |
| social vision. | | | | of products equipped with Plasmacluster Ion |
| Chronological History of Plasmacluster Ion | | | | technology had reached 20 million units in 58 |
| Technology | | | | countries around the world. |
| On 19 February 2001, Sharp announced that it | | | | But what is worthy of greater attention was that |
| had developed the world's first Plasmacluster Ion | | | | in this same announcement, Sharp revealed their |
| air purification technology, described as airborne | | | | phased marketing strategy of Plasmacluster Ion |
| ions surrounding germs and odors. | | | | technology. The concept of strategic phases was |
| Interestingly, the first product to use this | | | | explained. Phase I focused on R&D of the |
| technology was launched earlier in 2000. An air | | | | technology. Phase II centered on efficacy of the |
| purifier (FU-L40X), it was described as using | | | | technology and Phase III will zero in on efficiency. |
| Plasmacluster Ion technology that releases | | | | Coincidentally, these phases are part of our 5 Key |
| inactivating positive and negative ions into the air | | | | Factors Air Purifier Review Model. At the core of |
| to surround and inactivate mold fungi. | | | | their marketing strategy is the concept of |
| On 3 September 2003, Sharp declared that it had | | | | academic marketing, the reliance on academia to |
| proof for the first time ever that Plasmacluster | | | | back up their technological claims. |
| Ions deactivate airborne mite allergens, a main | | | | Fawning Accolades Roll? |
| cause of asthma and atopic disorders. | | | | This review is not a fawning accolades roll - it is a |
| On 27 July 2004, Sharp announced that | | | | peek into Japanese methodology in achieving |
| Plasmacluster Ions inactivate airborne corona virus | | | | leadership and domination in whatever they set |
| - A World First. | | | | their minds to. That they may have invested |
| On 17 November 2004, Sharp explained the | | | | more money than any other player in the ionic air |
| mechanism for inactivating bacteria by | | | | purifier industry may be an understatement! |
| Plasmacluster Ions. | | | | The above chain of events from the year 2000 |
| A dramatic but seemingly unnoticed claim was | | | | reflects the absolute confidence of Sharp in the |
| made by Sharp on 6 June 2005 that | | | | integrity of the Plasmacluster Ion technology. |
| Plasmacluster Ions had been proven effective | | | | After almost a decade in the market, there is no |
| against airborne highly pathogenic H5N1 avian | | | | known legal action taken against Sharp for harm |
| influenza. | | | | arising from using Plasmacluster Ion technology. |
| On 21 November 2005, sales of Sharp products | | | | That this is a multi-billion business may not be an |
| equipped with Plasmacluster Ion technology | | | | exaggeration too. A Sharp air purifier costs about |
| reached 10 million units worldwide. | | | | US$500. They have crossed the 20 million mark |
| On 10 August 2006, Sharp introduced humidifying | | | | for various units sold with the technology. Using |
| features into air purifiers. This amplified the | | | | just US$250 per unit as a rough gauge, we are |
| effectiveness of Plasmacluster Ions. | | | | talking about a US$2.5 billion business that is |
| Stepping up the ante, on 3 August 2007, Sharp | | | | growing everyday. |
| proved the effectiveness of Plasmacluster Ions in | | | | Do not be surprised that the Sharp Plasmacluster |
| eliminating serratia bacteria in collaboration with Dr. | | | | Ion technology becomes the de facto standard of |
| Melvin First, Professor Emeritus, Harvard School | | | | air purification. All that is lacking is an independent |
| of Public Health. | | | | scientific peer review. I expect someone will |
| Another dramatic announcement by Sharp on 27 | | | | choose this very technology to be the debutante |
| August 2008 was headlined Higher Concentrations | | | | peer review for the ionic air purifier industry. |
| of Plasmacluster Ions Boost Virus Inactivation and | | | | What Next? |
| Elimination, Inhibit 99.9% of Airborne H5N1 Avian | | | | You will note that to date, Sharp's approach has |
| Influenza ('Bird Flu') Virus. The verification was in | | | | been to focus on efficacy (Phase II). They are |
| collaboration with Retroscreen Virology Ltd, a UK | | | | now moving on to effectiveness (Phase III). |